<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<HTML xmlns="http://www.w3.org/TR/REC-html40" xmlns:v =
"urn:schemas-microsoft-com:vml" xmlns:o =
"urn:schemas-microsoft-com:office:office" xmlns:w =
"urn:schemas-microsoft-com:office:word" xmlns:m =
"http://schemas.microsoft.com/office/2004/12/omml"><HEAD><TITLE>Dear <Name>, president of <Chapter>,</TITLE>
<META content="text/html; charset=iso-8859-1" http-equiv=Content-Type>
<META name=GENERATOR content="MSHTML 8.00.6001.19154">
<STYLE>@font-face {
font-family: Calibri;
}
@font-face {
font-family: Tahoma;
}
@page {mso-endnote-separator: url("cid:header.htm\@01CCB335.8538C2F0") es; mso-endnote-continuation-separator: url("cid:header.htm\@01CCB335.8538C2F0") ecs; }
@page WordSection1 {size: 8.5in 11.0in; margin: 1.0in 1.0in 1.0in 1.0in; }
P.MsoNormal {
MARGIN: 0in 0in 0pt; FONT-FAMILY: "Calibri","sans-serif"; FONT-SIZE: 11pt
}
LI.MsoNormal {
MARGIN: 0in 0in 0pt; FONT-FAMILY: "Calibri","sans-serif"; FONT-SIZE: 11pt
}
DIV.MsoNormal {
MARGIN: 0in 0in 0pt; FONT-FAMILY: "Calibri","sans-serif"; FONT-SIZE: 11pt
}
P.MsoHeader {
MARGIN: 0in 0in 0pt; FONT-FAMILY: "Calibri","sans-serif"; FONT-SIZE: 11pt; mso-style-priority: 99; mso-style-link: "Header Char"
}
LI.MsoHeader {
MARGIN: 0in 0in 0pt; FONT-FAMILY: "Calibri","sans-serif"; FONT-SIZE: 11pt; mso-style-priority: 99; mso-style-link: "Header Char"
}
DIV.MsoHeader {
MARGIN: 0in 0in 0pt; FONT-FAMILY: "Calibri","sans-serif"; FONT-SIZE: 11pt; mso-style-priority: 99; mso-style-link: "Header Char"
}
P.MsoFooter {
MARGIN: 0in 0in 0pt; FONT-FAMILY: "Calibri","sans-serif"; FONT-SIZE: 11pt; mso-style-priority: 99; mso-style-link: "Footer Char"
}
LI.MsoFooter {
MARGIN: 0in 0in 0pt; FONT-FAMILY: "Calibri","sans-serif"; FONT-SIZE: 11pt; mso-style-priority: 99; mso-style-link: "Footer Char"
}
DIV.MsoFooter {
MARGIN: 0in 0in 0pt; FONT-FAMILY: "Calibri","sans-serif"; FONT-SIZE: 11pt; mso-style-priority: 99; mso-style-link: "Footer Char"
}
A:link {
FONT-FAMILY: "Times New Roman","serif"; COLOR: blue; TEXT-DECORATION: underline; mso-style-priority: 99
}
SPAN.MsoHyperlink {
FONT-FAMILY: "Times New Roman","serif"; COLOR: blue; TEXT-DECORATION: underline; mso-style-priority: 99
}
A:visited {
COLOR: purple; TEXT-DECORATION: underline; mso-style-priority: 99
}
SPAN.MsoHyperlinkFollowed {
COLOR: purple; TEXT-DECORATION: underline; mso-style-priority: 99
}
P.MsoPlainText {
MARGIN: 0in 0in 0pt; FONT-FAMILY: "Calibri","sans-serif"; FONT-SIZE: 11pt; mso-style-priority: 99; mso-style-link: "Plain Text Char"
}
LI.MsoPlainText {
MARGIN: 0in 0in 0pt; FONT-FAMILY: "Calibri","sans-serif"; FONT-SIZE: 11pt; mso-style-priority: 99; mso-style-link: "Plain Text Char"
}
DIV.MsoPlainText {
MARGIN: 0in 0in 0pt; FONT-FAMILY: "Calibri","sans-serif"; FONT-SIZE: 11pt; mso-style-priority: 99; mso-style-link: "Plain Text Char"
}
P.MsoAcetate {
MARGIN: 0in 0in 0pt; FONT-FAMILY: "Tahoma","sans-serif"; FONT-SIZE: 8pt; mso-style-priority: 99; mso-style-link: "Balloon Text Char"
}
LI.MsoAcetate {
MARGIN: 0in 0in 0pt; FONT-FAMILY: "Tahoma","sans-serif"; FONT-SIZE: 8pt; mso-style-priority: 99; mso-style-link: "Balloon Text Char"
}
DIV.MsoAcetate {
MARGIN: 0in 0in 0pt; FONT-FAMILY: "Tahoma","sans-serif"; FONT-SIZE: 8pt; mso-style-priority: 99; mso-style-link: "Balloon Text Char"
}
P.MsoNoSpacing {
MARGIN: 0in 0in 0pt; FONT-FAMILY: "Calibri","sans-serif"; FONT-SIZE: 11pt; mso-style-priority: 99
}
LI.MsoNoSpacing {
MARGIN: 0in 0in 0pt; FONT-FAMILY: "Calibri","sans-serif"; FONT-SIZE: 11pt; mso-style-priority: 99
}
DIV.MsoNoSpacing {
MARGIN: 0in 0in 0pt; FONT-FAMILY: "Calibri","sans-serif"; FONT-SIZE: 11pt; mso-style-priority: 99
}
SPAN.PlainTextChar {
FONT-FAMILY: "Calibri","sans-serif"; mso-style-priority: 99; mso-style-link: "Plain Text"; mso-style-name: "Plain Text Char"
}
SPAN.BalloonTextChar {
FONT-FAMILY: "Times New Roman","serif"; mso-style-priority: 99; mso-style-link: "Balloon Text"; mso-style-name: "Balloon Text Char"
}
SPAN.HeaderChar {
FONT-FAMILY: "Calibri","sans-serif"; mso-style-priority: 99; mso-style-link: Header; mso-style-name: "Header Char"
}
SPAN.FooterChar {
FONT-FAMILY: "Calibri","sans-serif"; mso-style-priority: 99; mso-style-link: Footer; mso-style-name: "Footer Char"
}
.MsoChpDefault {
FONT-FAMILY: "Calibri","sans-serif"; FONT-SIZE: 11pt; mso-style-type: export-only
}
DIV.WordSection1 {
page: WordSection1
}
</STYLE>
<!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]--></HEAD>
<BODY lang=EN-US link=blue bgColor=#ffffff vLink=purple>
<DIV><FONT size=4>If interested take the survey.</FONT></DIV>
<DIV><FONT size=4>Thank you.</FONT></DIV>
<DIV> </DIV>
<DIV><FONT size=4></FONT><FONT size=4></FONT><BR>Have a blessed and wonderful
day.<BR>Blessings!<BR>Sincerely,<BR>Melissa and Pj Green<BR>Failure is not
fatal, but failure to change might be<BR></DIV>
<DIV style="FONT: 10pt arial">----- Original Message -----
<DIV style="BACKGROUND: #e4e4e4; font-color: black"><B>From:</B> <A
title=Annie.Gallagher@vandapharma.com
href="mailto:Annie.Gallagher@vandapharma.com">Annie Gallagher</A> </DIV>
<DIV><B>To:</B> <A title=graduate56@juno.com
href="mailto:graduate56@juno.com">graduate56@juno.com</A> </DIV>
<DIV><B>Sent:</B> Monday, December 05, 2011 8:06 AM</DIV>
<DIV><B>Subject:</B> Thanks For Your Support</DIV></DIV>
<DIV><BR></DIV>
<DIV class=WordSection1>
<P class=MsoNormal>Dear Melissa Green, President of NFB of Colorado Greeley
Chapter,</P>
<P class=MsoNormal><o:p> </o:p></P>
<P class=MsoNormal>NFB National has recently sent out information about an
article on <SPAN style="COLOR: #444444" lang=EN>Improving Sleep and Alertness in
the Blind </SPAN>recently published in the Matilda Ziegler Magazine for the
Blind. A little over a year ago, we launched a clinical study to evaluate a
potential treatment for Non-24-Hour Sleep-Wake Disorder. Non-24 is a
chronic sleep disorder that affects approximately 50% of individuals who are
totally blind. Their inability to perceive light causes a severe disruption
of the 24-hour sleep-wake pattern causing cyclical bouts of nighttime
sleeplessness and excessive daytime fatigue and napping. The disorder can
make it extremely difficult to do well in school, hold down a job or have
satisfying relationships. Non-24 has been called an “invisible disability,”
and can go undiagnosed for years. </P>
<P class=MsoNormal><o:p> </o:p></P>
<P class=MsoNormal>Recently, our 24SleepWake website has launched an exclusive
new audio series, “Meet the Experts: Sleep Disorders in the Blind.” This 3 part
series features interviews with leading sleep experts and covers all
aspects of Non-24-Hour Sleep-Wake Disorder, including its impact on the
blind community. The two that have been released are linked below.</P>
<P class=MsoNoSpacing><A
href="http://www.24sleepwake.com/en/index.php/news_info/exclusive_audio_series/">http://www.24sleepwake.com//en/index.php/news_info/exclusive_audio_series/</A></P>
<P class=MsoNoSpacing><o:p> </o:p></P>
<P class=MsoNoSpacing><A
href="http://www.24sleepwake.com/en/index.php/news_info/exclusive_audio_series1/">http://www.24sleepwake.com//en/index.php/news_info/exclusive_audio_series1/</A></P>
<P class=MsoNormal><o:p> </o:p></P>
<P class=MsoNormal>The enrollment deadline for our clinical research study is
forthcoming. Without enough patients in the study, it will be difficult to
develop a treatment for this severe condition. Vanda appreciates any assistance
you can give in spreading awareness about Non-24. For every person who completes
our sleep survey, Vanda will donate $25. Thus far, we have been able to donate
more than $ 8,000 to the NFB national and local NFB chapters. See below the
announcement about this survey and our study.</P>
<P class=MsoNormal><o:p> </o:p></P>
<P class=MsoNormal><o:p> </o:p></P>
<P class=MsoNormal>Sincerely,</P>
<P class=MsoNormal>Annie Gallagher</P>
<P class=MsoNormal>Outreach Specialist</P>
<P class=MsoNormal>Vanda Pharmaceuticals Inc.</P>
<P class=MsoNormal>(240) 599-4524<o:p></o:p></P>
<P class=MsoNormal><SPAN style="COLOR: #1f497d"><A
href="mailto:Annie.gallagher@vandapharma.com">Annie.gallagher@vandapharma.com</A>
<o:p></o:p></SPAN></P>
<P class=MsoNormal><o:p> </o:p></P>
<P class=MsoNormal>For more information on Non-24 visit<SPAN
style="COLOR: #1f497d"> </SPAN><A
href="http://www.24sleepwake.com">www.24sleepwake.com</A><SPAN
style="COLOR: #1f497d">, </SPAN>follow us on Twitter<SPAN
style="COLOR: #1f497d"> </SPAN><A
href="http://twitter.com/#!/24SleepWake">@24SleepWake</A><SPAN
style="COLOR: #1f497d"> </SPAN>or “<A
href="https://www.facebook.com/pages/24SleepWake/269350616423191?ref=nf&sk=wall">Like</A>”<SPAN
style="COLOR: #1f497d"> </SPAN>us on Facebook!<SPAN
style="COLOR: #1f497d"><o:p></o:p></SPAN></P>
<P class=MsoNormal><o:p> </o:p></P>
<P class=MsoNormal><o:p> </o:p></P>
<P class=MsoNormal><o:p> </o:p></P>
<P class=MsoNormal><o:p> </o:p></P>
<P class=MsoNormal><o:p> </o:p></P>
<P class=MsoNormal><o:p> </o:p></P>
<P class=MsoNormal><B><U><SPAN
style="FONT-FAMILY: 'Arial','sans-serif'">Announcement:<o:p></o:p></SPAN></U></B></P>
<P class=MsoNormal><SPAN style="FONT-FAMILY: 'Arial','sans-serif'">Do you ever
feel like your sleep patterns are different than the rest of the world? If you
are totally blind, this could be due to a real sleep problem related to the lack
of light needed by your body's internal clock. If you think you might be
affected, you can call 1-888-389-7033 or email </SPAN><A
title=blocked::mailto:info@non24registry.com
href="mailto:info@non24registry.com"><SPAN
style="FONT-FAMILY: 'Arial','sans-serif'">info@non24registry.com</SPAN></A><SPAN
style="FONT-FAMILY: 'Arial','sans-serif'"> to take a sleep survey or to
learn more about an ongoing clinical research study, or go to </SPAN><A
href="http://www.non24registry.com"><SPAN
style="FONT-FAMILY: 'Arial','sans-serif'">www.non24registry.com</SPAN></A><SPAN
style="FONT-FAMILY: 'Arial','sans-serif'"><o:p></o:p></SPAN></P>
<P class=MsoNoSpacing><o:p> </o:p></P></DIV></BODY></HTML>